首页> 外文期刊>Circulation. Genomic and precision medicine. >Investigation of Copy Number Variation in South African Patients With Congenital Heart Defects
【24h】

Investigation of Copy Number Variation in South African Patients With Congenital Heart Defects

机译:南非先天性心脏缺陷患者拷贝数变异的调查

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Congenital heart disease (CH D) is a leading non-infectious cause of pediatric morbidity and mortality worldwide. Although the etiology of CHD is poorly understood, genetic factors including copy number variants (CNVs) contribute to the risk of CHD in individuals of European ancestry. The presence of rare CNVs in African CHD populations is unknown. This study aimed to identify pathogenic and likely pathogenic CNVs in South African patients with CHD.METHODS: Genotyping was performed on 90 patients with nonsyndromic CHD using the Affymetrix CytoScan HD platform. These data were used to identify large, rare CNVs in known CHD-associated genes and candidate genes.RESULTS: We identified eight CNVs overlapping known CHD-associated genes (GATA4, CRKL, TBX1, FLT4, B3GAT3, NSD1)in six patients. The analysis also revealed CNVs encompassing five candidate genes likely to play a role in the development of CHD (DGCR8, KDM2A, JARID2, FSTL1, CYFIP1) in five patients. One patient was found to have 47, XXY karyotype. We report a total discovery yield of 6.7%, with 5.6% of the cohort carrying pathogenic or likely pathogenic CNVs expected to cause the observed phenotypes.CONCLUSIONS: In this study, we show that chromosomal microarray is an effective technique for identifying CNVs in African patients diagnosed with CHD and have demonstrated results similar to previous CHD genetic studies in Europeans. Novel potential CHD genes were also identified, indicating the value of genetic studies of CHD in ancestrally diverse populations.
机译:背景:先天性心脏病(CH D)是一个儿童的主要非感染性原因全球发病率和死亡率。冠心病的病因知之甚少,遗传因素,包括拷贝数变异(CNVs)有助于个人冠心病的风险欧洲血统。非洲冠心病人群是未知的。旨在确定致病性和可能致病基因拷贝数异变在南非的患者冠心病。nonsyndromic冠心病患者使用Affymetrix CytoScan高清平台。用于识别大型、稀有基因拷贝数异变在已知的CHD-associated基因和候选基因。我们确定了八个基因拷贝数异变重叠B3GAT3 NSD1)在六个病人。揭示基因拷贝数异变包括五个候选基因可能在冠心病的发展发挥作用病人。核型。6.7%, 5.6%的人群携带致病或可能致病基因拷贝数异变将导致观察到的表型。我们表明,染色体微阵列是一种有效的技术来识别基因拷贝数异变非洲病人诊断为冠心病,演示结果类似于以前的冠心病欧洲人的基因研究。基因也确认,指示值冠心病的遗传研究祖先地多样化人群。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号